Edwina Edgeworth of Monroe has lung cancer that did not improve on a standard chemotherapy. But since she began taking an experimental drug, called AZD9291, as part of a clinical trial at Levine Cancer Institute, he tumor has shrunk by nearly 60 percent
Edwina Edgeworth of Monroe has lung cancer that did not improve on a standard chemotherapy. But since she began taking an experimental drug, called AZD9291, as part of a clinical trial at Levine Cancer Institute, he tumor has shrunk by nearly 60 percent Carolinas HealthCare System
Edwina Edgeworth of Monroe has lung cancer that did not improve on a standard chemotherapy. But since she began taking an experimental drug, called AZD9291, as part of a clinical trial at Levine Cancer Institute, he tumor has shrunk by nearly 60 percent Carolinas HealthCare System